Restorbio, inc. (TORC)
CashFlow / Yearly
Dec'19Dec'18Dec'17
Operating activities:
Net loss

-82,739

-37,614

-33,778

Adjustments to reconcile net loss to net cash used in operating activities:
Accretion on marketable securities

1,020

673

-

Depreciation and amortization expense

125

80

5

Loss on disposal of property and equipment

-53

-

-

Stock-based compensation expense

3,694

2,793

470

Change in fair value of tranche liability

-

-

14,896

Expense related to acquisition of intellectual property

-

-

3,157

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

274

630

876

Accounts payable

3,727

1,597

1,392

Accrued liabilities

2,756

-1,022

3,749

Other liabilities

-4

19

-

Net cash used in operating activities

-73,682

-35,450

-10,985

Purchases of property and equipment

271

362

44

Maturities of marketable securities

141,500

7,500

-

Purchases of marketable securities

97,103

107,854

-

Net cash provided by (used in) investing activities

44,126

-100,716

-44

Financing activities:
Proceeds from public offering, net of issuance costs

49,747

90,908

-

Proceeds from at-the-market offering, net of issuance costs

6,716

-

-

Deferred offering costs

-

-970

-568

Taxes paid related to net share settlement of restricted stock units

20

-

-

Proceeds from exercise of stock options

6

5

-

Net cash (used in) provided by financing activities

56,449

89,943

64,378

Net increase in cash, cash equivalents and restricted cash

26,893

-46,223

53,349

Supplemental disclosure of non-cash investing and financing activities:
Cash paid for income taxes

62

-

-

Conversion of redeemable convertible preferred stock into common stock

-

81,620

-

Series A Redeemable Convertible Preferred Stock
Proceeds from issuance of redeemable convertible preferred stock

-

-

25,000

Series B Redeemable Convertible Preferred Stock
Proceeds from issuance of redeemable convertible preferred stock

-

-

39,946